Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says Two Eye Drops Passed On-Site Inspection Of NMPA

May 24 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * BIMATOPROST TIMOLOL EYE DROP AND EPINASTINE HCL EYE DROP
PASSED
ON-SITE INSPECTION OF NMPA

Source text for Eikon:  ID:nHKS5b9vWn 
Further company coverage:  6622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news